Cargando…
Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes
We report the case of a patient with type 1 diabetes who developed acute severe diabetic ketoacidosis following ingestion of an energy supplement containing caffeine. Some 95% of the US adult population consume caffeine, and the general perception is that there are no negative consequences for healt...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346890/ https://www.ncbi.nlm.nih.gov/pubmed/30755983 http://dx.doi.org/10.12890/2018_000957 |
_version_ | 1783389843311558656 |
---|---|
author | Hamed, Ehab |
author_facet | Hamed, Ehab |
author_sort | Hamed, Ehab |
collection | PubMed |
description | We report the case of a patient with type 1 diabetes who developed acute severe diabetic ketoacidosis following ingestion of an energy supplement containing caffeine. Some 95% of the US adult population consume caffeine, and the general perception is that there are no negative consequences for health. The upper limit of safe consumption is less than 400 mg per day. However, acute ingestion of high doses of caffeine may cause significant metabolic changes that can be fatal. Here the patient consumed a toxic dose of caffeine causing unpleasant and puzzling symptoms, vomiting and, following omission of his long-acting basal insulin, severe diabetic ketoacidosis. As the sports nutrition market continues to expand, providers and manufacturers have a responsibility to give clear and accurate dosing instructions as well as side effect profiles for their products, particularly for diabetic patients. LEARNING POINTS: The impact of caffeine on blood glucose levels has implications for people with diabetes who may be thinking of consuming supplements containing caffeine. Providers of sports supplements have a responsibility to provide an accurate description of the side effects with a clear warning for diabetic patients. Legislators should review protocols for regulating the sports and nutritional supplements industry. |
format | Online Article Text |
id | pubmed-6346890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-63468902019-02-12 Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes Hamed, Ehab Eur J Case Rep Intern Med Articles We report the case of a patient with type 1 diabetes who developed acute severe diabetic ketoacidosis following ingestion of an energy supplement containing caffeine. Some 95% of the US adult population consume caffeine, and the general perception is that there are no negative consequences for health. The upper limit of safe consumption is less than 400 mg per day. However, acute ingestion of high doses of caffeine may cause significant metabolic changes that can be fatal. Here the patient consumed a toxic dose of caffeine causing unpleasant and puzzling symptoms, vomiting and, following omission of his long-acting basal insulin, severe diabetic ketoacidosis. As the sports nutrition market continues to expand, providers and manufacturers have a responsibility to give clear and accurate dosing instructions as well as side effect profiles for their products, particularly for diabetic patients. LEARNING POINTS: The impact of caffeine on blood glucose levels has implications for people with diabetes who may be thinking of consuming supplements containing caffeine. Providers of sports supplements have a responsibility to provide an accurate description of the side effects with a clear warning for diabetic patients. Legislators should review protocols for regulating the sports and nutritional supplements industry. SMC Media Srl 2018-10-24 /pmc/articles/PMC6346890/ /pubmed/30755983 http://dx.doi.org/10.12890/2018_000957 Text en © EFIM 2018 This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Articles Hamed, Ehab Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes |
title | Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes |
title_full | Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes |
title_fullStr | Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes |
title_full_unstemmed | Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes |
title_short | Caffeine Toxicity Following Ingestion of an Exercise Supplement by a Patient with Type 1 Diabetes |
title_sort | caffeine toxicity following ingestion of an exercise supplement by a patient with type 1 diabetes |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346890/ https://www.ncbi.nlm.nih.gov/pubmed/30755983 http://dx.doi.org/10.12890/2018_000957 |
work_keys_str_mv | AT hamedehab caffeinetoxicityfollowingingestionofanexercisesupplementbyapatientwithtype1diabetes |